2003
DOI: 10.1046/j.1365-2036.17.s2.17.x
|View full text |Cite
|
Sign up to set email alerts
|

Crohn's disease: monitoring disease activity

Abstract: Summary A global measurement of Crohn's disease activity, comprising clinical, endoscopic, biochemical and pathological features is not available yet and perhaps is unobtainable. In this review we analyse the most used and validated clinical indices (Crohn's Disease Activity Index [CDAI], Perianal Disease Activity Index [PDAI], fistula drainage assessment), quality of life scores (Inflammatory Bowel Disease Questionnaire [IBDQ]), sub‐clinical markers (C‐reactive protein, faecal calprotectin, intestinal permeab… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
120
1
8

Year Published

2006
2006
2021
2021

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 199 publications
(131 citation statements)
references
References 34 publications
2
120
1
8
Order By: Relevance
“…In the absence of a " gold standard " for the measurement of disease activity, severity is established on clinical parameters, systemic manifestations, and the global impact of the disease on the individual ' s quality of life (44,78,79) . Additional factors that impact on therapy include the assessment of growth and nutrition, extraintestinal complications, therapy-induced complications, functional ability, social and emotional support and resources, and education about the disease (77) .…”
Section: Determining Disease Activitymentioning
confidence: 99%
“…In the absence of a " gold standard " for the measurement of disease activity, severity is established on clinical parameters, systemic manifestations, and the global impact of the disease on the individual ' s quality of life (44,78,79) . Additional factors that impact on therapy include the assessment of growth and nutrition, extraintestinal complications, therapy-induced complications, functional ability, social and emotional support and resources, and education about the disease (77) .…”
Section: Determining Disease Activitymentioning
confidence: 99%
“…In the past, this evaluation was based on clinical indexes, mainly the Crohn's Disease Activity Index (CDAI), integrated by laboratory parameters including C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and orosomucoids, and endoscopic findings [2,3]. Indeed, endoscopy can assess only mucosal inflammation, which, in a transmural disease like CD, might not be enough [4].…”
Section: Introductionmentioning
confidence: 99%
“…1 , 2 , 3 , 4 , 5 , 6 Although considered the gold standard method for assessment of intestinal inflammation, ileo-colonoscopy has the disadvantage of being invasive, time-consuming, expensive, and sometimes uncomfortable for patients.…”
Section: Introductionmentioning
confidence: 99%